Education | Health Care | Research | Site Map


Search:
Division of Infectious Disease
 
     
Division of Infectious Disease
 
Home
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Penn CFAR
Botswana-UPenn Partnership
Seminars
Faculty
Adjunct Faculty
Administrative Contacts
Outpatient Clinics
News

 

Faculty

 
 

Mindy Schuster, M.D.

Dr. Schuster's main interests are infectious complications of cancer chemotherapy and bone marrow/stem cell transplantation, as well as the treatment and prevention of invasive fungal infections in immunosuppressed hosts. She is actively engaged in several research projects investigating the epidemiology, risk factors, prevention and treatment of fungal infections in solid organ and bone marrow/stem cell transplant patients, and in high risk intensive care unit patients.

Selected publications:

Schuster MG, Edwards JE, Sobel JD, et al. Empirical fluconazole versus placebo for intensive care unit patients:A randomized trial. Annals of Internal Medicine, 2008; 149(2); 83-90.

Pappas PG, Andes D, Schuster M, et al. Invasive Fungal Infections in Low Risk Liver Transplant Recipients: A Multicenter Prospective Observational Study. American Journal of Transplantation. 2006;6:386-391.

Hagen EA, Stern H, Porter D, Duffy K, Foley K, Luger S, Schuster SJ, Stadtmauer E, Schuster MG. High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation- Clin Infect Dis 36:9-16,2003.

Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli H, Yanovich S, Stiff P, Greenberg R, Donowitz G, Lee J, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdiere M, Perfect J, Garber G, Fioritoni G, Anaissie E, for the NIAID Mycoses Study Group. Voriconazole versus liposomal amphotericin B for emipirical antifungal therapy in perisistently febrile neutropenic patients:A prospective, randomized, multicenter, international trial.- N Eng J Med 346(4): 225-34, 2002.

Barton T, Collis T, Stadmauer E, Schuster M. Infectious complications during the year following peripheral stem cell or autologous bone marrow transplantation for breast cancer. -Clin Infect Dis 32(3):391-5, 2001.

Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC. A randomized multicenter trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients. - Am J Med 108(4):282-9, 2000.

Cagnoni PJ, Walsh TJ, Prendergast, MM, Bodensteiner D, Heimenz S, Greenberg RN, Arndt CA, Schuster M, et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.: Journ Clin Oncology 18(12):2476-83, 2000.

Walsh TJ, Finberg R, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg R, Dummer S, Schuster M, Holcenberg JS, Dismukes WE, and the NIAID-Mycoses Study Group. A randomized, double-blind, multicenter trial of liposomal amphotericin B versus conventional amphotericin B for empiricial antifungal therapy of persistently febrile neutropenic patients. N Eng J Med.340(10),764-771,1999.

Contact:
Mindy Schuster, M.D.
9047 West Gates
3400 Spruce Street
Philadelphia, PA 19104-4283
schustem@mail.med.upenn.edu
(215) 662-4645

Education:
Medical School: Yale University
ID Training: University of Pennsylvania
Academic Rank: Associate Professor of Medicine